Modulation of Bleomycin-induced oxidative stress and pulmonary fibrosis by ginkgetin in mice via AMPK.

Guoqing Ren,Gonghao Xu,Renshi Li,Hai-feng Xie,Zhengguo Cui,Lei Wang,Chao-Yu Zhang

DOI: https://doi.org/10.2174/1874467215666220304094058

2022-03-04

Current Molecular Pharmacology

Abstract:BACKGROUND Ginkgetin, a flavonoid extracted from ginkgo biloba, has been shown to exhibit broad anti-inflammatory, anticancer, and antioxidative bioactivity. The extract of Ginkgo folium has been reported on attenuating bleomycin-induced pulmonary fibrosis, but the anti-fibrotic effects of ginkgetin is still unclear. This study was intended to investigate the protective effects of ginkgetin against experimental pulmonary fibrosis and its underlying mechanism. METHODS In vivo, bleomycin (5 mg/kg) in 50 μL saline was administrated intratracheally in mice. One week after bleomycin administration, ginkgetin (25 or 50 mg/kg) or nintedanib (40 mg/kg) were administrated intragastrically daily for 14 consecutive days. In vitro, the AMPK-siRNA transfection in primary lung fibroblasts further verified the regulation effect of ginkgetin on AMPK. RESULTS Administration of bleomycin caused characteristic histopathology structural changes with elevated lipid peroxidation, pulmonary fibrosis indexes, and inflammatory mediators. The bleomycin-induced alteration was normalized by ginkgetin intervention. Moreover, this protective effect of ginkgetin (20 mg/kg) was equivalent to nintedanib (40 mg/kg). AMPK-siRNA transfection in primary lung fibroblasts markedly blocked TGF-1-induced myofibroblasts transdifferentiation and abolished oxidative stress. CONCLUSIONS All these results suggested that ginkgetin exerted the ameliorative effects on bleomycin-induced oxidative stress and lung fibrosis mainly through an AMPK-dependent manner.

Medicine